A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine

Neurol Sci. 2022 Feb;43(2):771-773. doi: 10.1007/s10072-021-05763-5. Epub 2021 Nov 23.

Authors

Dong-Woo Ryu¹, Eun-Ye Lim², A-Hyun Cho²

Affiliations

¹ Department of Neurology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, Seoul, 07345, Republic of Korea. manrew@catholic.ac.kr.
² Department of Neurology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, Seoul, 07345, Republic of Korea.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Advisory Committees
BNT162 Vaccine*
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine